2 KUTV

WASHINGTON POST
HEALTH 202: The newest way to test for coronavirus: Spitting in a tube

Using Utah technology, researchers at Rutgers University have discovered a breakthrough that opens the door for mass COVID-19 testing. Spectrum DNA’s SDNA-1000 Whole Saliva DNA Collection Device is being used by researchers at RUCDR Infinite Biologics at Rutgers University and successfully validated that saliva is an equally viable source for COVID-19 detection as other biomaterials, supplanting the need for scarce testing supplies.

According to a press release, saliva testing is a new development that, under a medical provider’s direction, allows for simple self-administered sample collection that even those in quarantine or self-isolation can use. This same device has been proven effective by millions of people for consumer DNA ancestry-type tests.

According to the researchers, its unique properties including the blue preservation solution excellently preserved the COVID-19 viral RNA for testing while killing the active virus preventing its spread to medical and clinical staff.

Bill Phillips, Spectrum’s Chief Operating Officer, said in a prepared statement:

This is it. This is what makes America so great. Challenge and adversity throw up roadblocks and we partner together to discover, and deliver, not only an answer to the supply shortage for sample collection but uncover a solution that is actually better than what we were using in the first place.

RUCDR is currently testing for COVID-19 using the Spectrum DNA SDNA-1000 whole saliva collection device leveraging two easily accessible COVID-19 detection assays under EUA from the FDA.

Spectrum Solutions COVID-19 SDNA-1000 Saliva Collection Kit

© Spectrum Solutions™ Saliva Collection Device | Photo Credit: Leslie Titus Bryant

Using Utah technology, researchers at Rutgers University have discovered a breakthrough that opens the door for mass COVID-19 testing. Spectrum DNA’s SDNA-1000 Whole Saliva DNA Collection Device is being used by researchers at RUCDR Infinite Biologics at Rutgers University and successfully validated that saliva is an equally viable source for COVID-19 detection as other biomaterials, supplanting the need for scarce testing supplies.

According to a press release, saliva testing is a new development that, under a medical provider’s direction, allows for simple self-administered sample collection that even those in quarantine or self-isolation can use. This same device has been proven effective by millions of people for consumer DNA ancestry-type tests.

According to the researchers, its unique properties including the blue preservation solution excellently preserved the COVID-19 viral RNA for testing while killing the active virus preventing its spread to medical and clinical staff.

Bill Phillips, Spectrum’s Chief Operating Officer, said in a prepared statement:

This is it. This is what makes America so great. Challenge and adversity throw up roadblocks and we partner together to discover, and deliver, not only an answer to the supply shortage for sample collection but uncover a solution that is actually better than what we were using in the first place.

RUCDR is currently testing for COVID-19 using the Spectrum DNA SDNA-1000 whole saliva collection device leveraging two easily accessible COVID-19 detection assays under EUA from the FDA.

Spectrum Solutions COVID-19 SDNA-1000 Saliva Collection Kit

© Spectrum Solutions™ Saliva Collection Device | Photo Credit: Leslie Titus Bryant

2KUTV News- Spectrum Solutions Saliva Collection for COVID-19 Testing

Spectrum
in the News

Spectrum
in the News

Noninvasive
Saliva Diagnostics

This changes everything

Health is a dynamic state of well-being. Healthcare providers and researchers have long believed that changes in our saliva record our ongoing state-of-health story. Interestingly, saliva acts as a wide resource of genomic information useful for identifying and monitoring in real-time a disease as well as its state of progression. Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant.

Spectrum’s technically-superior saliva collection systems have not only been engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications but deliver the safest, most robust biomaterial for the earliest detection and diagnosis of disease and infection.

  • Saliva provides the earliest path to critical detection and diagnosis
  • Saliva contains the entire library of proteins, hormones, antibodies, and other molecular compounds measured in routine blood tests
  • First EUA authorized saliva collection device for COVID-19 testing & authorized device for direct-to-patient at-home sample self-collection
  • Used in supervised & unsupervised sample collection LDT workflows of symptomatic & asymptomatic users
  • Pain-free, non-invasive, & safe – ideal for those needing frequent & repeat testing
  • In-device live virus inactivation at ambient temps (COVID-19 EUA validated data)
  • Eliminates hooded containment of samples arriving at the testing lab
  • No temperature-controlled storage or transport of collected saliva samples
  • Single device for DNA & viral RNA applications
  • Safest collection approach & most robust biomaterial for detecting COVID-19
  • Delivers 99.998% highest levels of testing accuracy & sensitivity
  • Formulation identifies infections at its earliest stage from as few as 200 copies/ml (lateral flow rapid tests need 10,000-20,000 copies/ml)
  • A single preserved saliva sample provides opportunity for multiple tests
  • Over two weeks of post-collection stability with no degradation in sample efficacy
  • System maintains critical bio-sample consistency
  • Mass-testing scalability & easy device integration using validated and supported processes
  • Mitigates any risk of infection throughout the testing process
  • Pinpoint life-cycle stage of active viral infection
  • Eliminates UN3373 shipping designation with clearance from USPS, FedEx, & UPS
  • Delivers the highest levels of testing accuracy using qualified extraction chemistries
Questions, Let’s Connect!

Noninvasive
Saliva Diagnostics

This changes everything

Health is a dynamic state of well-being. Healthcare providers and researchers have long believed that changes in our saliva record our ongoing state-of-health story. Interestingly, saliva acts as a wide resource of genomic information useful for identifying and monitoring in real-time a disease as well as its state of progression. Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant.

Spectrum’s technically-superior saliva collection systems have not only been engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications but deliver the safest, most robust biomaterial for the earliest detection and diagnosis of disease and infection.

  • Saliva provides the earliest path to critical detection and diagnosis
  • Saliva contains the entire library of proteins, hormones, antibodies, and other molecular compounds measured in routine blood tests
  • First EUA authorized saliva collection device for COVID-19 testing & authorized device for direct-to-patient at-home sample self-collection
  • Used in supervised & unsupervised sample collection LDT workflows of symptomatic & asymptomatic users
  • Pain-free, non-invasive, & safe – ideal for those needing frequent & repeat testing
  • In-device live virus inactivation at ambient temps (COVID-19 EUA validated data)
  • Eliminates hooded containment of samples arriving at the testing lab
  • No temperature-controlled storage or transport of collected saliva samples
  • Single device for DNA & viral RNA applications
  • Safest collection approach & most robust biomaterial for detecting COVID-19
  • Delivers 99.998% highest levels of testing accuracy & sensitivity
  • Formulation identifies infections at its earliest stage from as few as 200 copies/ml (lateral flow rapid tests need 10,000-20,000 copies/ml)
  • A single preserved saliva sample provides opportunity for multiple tests
  • Over two weeks of post-collection stability with no degradation in sample efficacy
  • System maintains critical bio-sample consistency
  • Mass-testing scalability & easy device integration using validated and supported processes
  • Mitigates any risk of infection throughout the testing process
  • Pinpoint life-cycle stage of active viral infection
  • Eliminates UN3373 shipping designation with clearance from USPS, FedEx, & UPS
  • Delivers the highest levels of testing accuracy using qualified extraction chemistries
Questions, Let’s Connect!

Outside-of-the-Box Thinking, Inside-of-the-Box Clinical Innovation

Anywhere from customized testing solutions to new medical science product innovations–we’re here to help.

Outside-of-the-Box Thinking, Inside-of-the-Box Innovation

Anywhere from customized testing solutions to new medical science product innovations–we’re here to help.